1. Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?. Issue 9 (27th March 2007) Authors: Hjardem, Elisabeth; Østergaard, Mikkel; Pødenphant, Jan; Tarp, Ulrik; Andersen, Lis Smedegaard; Bing, Jette; Peen, Elisabeth; Lindegaard, Hanne Merete; Ringsdal, Vibeke Stevenius; Rødgaard, Anne; Skøt, Jens; Hansen, Annette; Mogensen, Hans Henrik; Unkerskov, Janne; Hetland, Merete Lund Journal: Annals of the rheumatic diseases Issue: Volume 66:Issue 9(2007) Page Start: 1184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗